nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—SLCO1B1—Sulfasalazine—Crohn's disease	0.167	0.262	CbGbCtD
Lovastatin—ABCC2—Sulfasalazine—Crohn's disease	0.146	0.23	CbGbCtD
Lovastatin—SLCO1A2—Prednisone—Crohn's disease	0.141	0.222	CbGbCtD
Lovastatin—CYP3A5—Sulfasalazine—Crohn's disease	0.0733	0.115	CbGbCtD
Lovastatin—CYP2C19—Prednisone—Crohn's disease	0.0473	0.0744	CbGbCtD
Lovastatin—ABCB1—Prednisone—Crohn's disease	0.0381	0.06	CbGbCtD
Lovastatin—CYP3A4—Prednisone—Crohn's disease	0.0229	0.036	CbGbCtD
Lovastatin—ABCC2—bile—Crohn's disease	0.0125	0.121	CbGeAlD
Lovastatin—Lupus-like syndrome—Mesalazine—Crohn's disease	0.00783	0.0473	CcSEcCtD
Lovastatin—ITGAL—epithelium—Crohn's disease	0.00684	0.0665	CbGeAlD
Lovastatin—ITGAL—mammalian vulva—Crohn's disease	0.00594	0.0577	CbGeAlD
Lovastatin—Hepatic necrosis—Mercaptopurine—Crohn's disease	0.00585	0.0353	CcSEcCtD
Lovastatin—PON3—mammalian vulva—Crohn's disease	0.00582	0.0566	CbGeAlD
Lovastatin—ITGAL—lymphoid tissue—Crohn's disease	0.00527	0.0512	CbGeAlD
Lovastatin—ITGAL—digestive system—Crohn's disease	0.00521	0.0506	CbGeAlD
Lovastatin—Lupus erythematosus—Mesalazine—Crohn's disease	0.00495	0.0299	CcSEcCtD
Lovastatin—HMGCR—gall bladder—Crohn's disease	0.00477	0.0464	CbGeAlD
Lovastatin—HDAC2—mouth—Crohn's disease	0.0047	0.0457	CbGeAlD
Lovastatin—UGT1A3—digestive system—Crohn's disease	0.00443	0.043	CbGeAlD
Lovastatin—Ache—Mesalazine—Crohn's disease	0.00399	0.0241	CcSEcCtD
Lovastatin—Cognitive impairment—Prednisone—Crohn's disease	0.00374	0.0226	CcSEcCtD
Lovastatin—Systemic lupus erythematosus—Mesalazine—Crohn's disease	0.00333	0.0201	CcSEcCtD
Lovastatin—Memory loss—Prednisone—Crohn's disease	0.00332	0.0201	CcSEcCtD
Lovastatin—Hepatic necrosis—Mesalazine—Crohn's disease	0.00317	0.0192	CcSEcCtD
Lovastatin—Transaminases increased—Mesalazine—Crohn's disease	0.00303	0.0183	CcSEcCtD
Lovastatin—ITGAL—lymph node—Crohn's disease	0.00297	0.0289	CbGeAlD
Lovastatin—Upset stomach—Mesalazine—Crohn's disease	0.00281	0.017	CcSEcCtD
Lovastatin—HDAC2—epithelium—Crohn's disease	0.00274	0.0266	CbGeAlD
Lovastatin—HDAC2—smooth muscle tissue—Crohn's disease	0.00264	0.0256	CbGeAlD
Lovastatin—HDAC2—skin of body—Crohn's disease	0.0026	0.0253	CbGeAlD
Lovastatin—UGT2B7—digestive system—Crohn's disease	0.00254	0.0247	CbGeAlD
Lovastatin—HMGCR—epithelium—Crohn's disease	0.00247	0.024	CbGeAlD
Lovastatin—HMGCR—smooth muscle tissue—Crohn's disease	0.00238	0.0231	CbGeAlD
Lovastatin—HMGCR—skin of body—Crohn's disease	0.00235	0.0228	CbGeAlD
Lovastatin—Jaundice cholestatic—Azathioprine—Crohn's disease	0.0023	0.0139	CcSEcCtD
Lovastatin—Cognitive disorder—Prednisone—Crohn's disease	0.00226	0.0136	CcSEcCtD
Lovastatin—UGT1A1—digestive system—Crohn's disease	0.00216	0.021	CbGeAlD
Lovastatin—HMGCR—mammalian vulva—Crohn's disease	0.00214	0.0208	CbGeAlD
Lovastatin—Tenderness—Mesalazine—Crohn's disease	0.00211	0.0128	CcSEcCtD
Lovastatin—HDAC2—lymphoid tissue—Crohn's disease	0.00211	0.0205	CbGeAlD
Lovastatin—Jaundice cholestatic—Mesalazine—Crohn's disease	0.0021	0.0127	CcSEcCtD
Lovastatin—Pancreatitis—Mercaptopurine—Crohn's disease	0.00209	0.0126	CcSEcCtD
Lovastatin—HDAC2—digestive system—Crohn's disease	0.00208	0.0202	CbGeAlD
Lovastatin—Vasculitis—Azathioprine—Crohn's disease	0.00207	0.0125	CcSEcCtD
Lovastatin—HMGCR—lymphoid tissue—Crohn's disease	0.0019	0.0185	CbGeAlD
Lovastatin—HMGCR—digestive system—Crohn's disease	0.00188	0.0182	CbGeAlD
Lovastatin—Musculoskeletal pain—Mesalazine—Crohn's disease	0.00187	0.0113	CcSEcCtD
Lovastatin—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.00184	0.0111	CcSEcCtD
Lovastatin—SLCO1B1—digestive system—Crohn's disease	0.0018	0.0175	CbGeAlD
Lovastatin—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00168	0.0102	CcSEcCtD
Lovastatin—Hepatic failure—Azathioprine—Crohn's disease	0.00164	0.00988	CcSEcCtD
Lovastatin—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.00154	0.0093	CcSEcCtD
Lovastatin—Photosensitivity—Mesalazine—Crohn's disease	0.00152	0.00921	CcSEcCtD
Lovastatin—Alopecia—Mercaptopurine—Crohn's disease	0.00151	0.00911	CcSEcCtD
Lovastatin—Hepatic failure—Mesalazine—Crohn's disease	0.00149	0.009	CcSEcCtD
Lovastatin—SLCO1A2—digestive system—Crohn's disease	0.00146	0.0142	CbGeAlD
Lovastatin—Myopathy—Prednisone—Crohn's disease	0.00139	0.00841	CcSEcCtD
Lovastatin—Arthritis—Mesalazine—Crohn's disease	0.00138	0.00833	CcSEcCtD
Lovastatin—ABCC2—digestive system—Crohn's disease	0.00136	0.0132	CbGeAlD
Lovastatin—Leukopenia—Mercaptopurine—Crohn's disease	0.00133	0.00804	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.00132	0.008	CcSEcCtD
Lovastatin—Arthralgia—Mercaptopurine—Crohn's disease	0.00126	0.00764	CcSEcCtD
Lovastatin—Pancreatitis—Azathioprine—Crohn's disease	0.00125	0.00753	CcSEcCtD
Lovastatin—Memory impairment—Prednisone—Crohn's disease	0.00124	0.00751	CcSEcCtD
Lovastatin—Abdominal discomfort—Azathioprine—Crohn's disease	0.00122	0.00736	CcSEcCtD
Lovastatin—Cramp muscle—Mesalazine—Crohn's disease	0.00121	0.00729	CcSEcCtD
Lovastatin—HDAC2—lymph node—Crohn's disease	0.00119	0.0115	CbGeAlD
Lovastatin—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00119	0.00717	CcSEcCtD
Lovastatin—CYP2C19—digestive system—Crohn's disease	0.00117	0.0114	CbGeAlD
Lovastatin—Influenza—Mesalazine—Crohn's disease	0.00116	0.00699	CcSEcCtD
Lovastatin—Anorexia—Mercaptopurine—Crohn's disease	0.00116	0.00698	CcSEcCtD
Lovastatin—Eosinophilia—Mesalazine—Crohn's disease	0.00115	0.00692	CcSEcCtD
Lovastatin—Pancreatitis—Mesalazine—Crohn's disease	0.00113	0.00686	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00112	0.00679	CcSEcCtD
Lovastatin—Abdominal discomfort—Mesalazine—Crohn's disease	0.00111	0.0067	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.0011	0.00668	CcSEcCtD
Lovastatin—HMGCR—lymph node—Crohn's disease	0.00107	0.0104	CbGeAlD
Lovastatin—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00106	0.00638	CcSEcCtD
Lovastatin—Decreased appetite—Mercaptopurine—Crohn's disease	0.00105	0.00637	CcSEcCtD
Lovastatin—Cataract—Prednisone—Crohn's disease	0.00102	0.0062	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00102	0.00618	CcSEcCtD
Lovastatin—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00101	0.00611	CcSEcCtD
Lovastatin—Urinary tract infection—Mesalazine—Crohn's disease	0.001	0.00606	CcSEcCtD
Lovastatin—Vasculitis—Prednisone—Crohn's disease	0.001	0.00604	CcSEcCtD
Lovastatin—Sinusitis—Mesalazine—Crohn's disease	0.000968	0.00585	CcSEcCtD
Lovastatin—Erythema multiforme—Azathioprine—Crohn's disease	0.000961	0.00581	CcSEcCtD
Lovastatin—Body temperature increased—Mercaptopurine—Crohn's disease	0.000958	0.00579	CcSEcCtD
Lovastatin—Hepatitis—Mesalazine—Crohn's disease	0.000926	0.0056	CcSEcCtD
Lovastatin—CYP3A5—digestive system—Crohn's disease	0.000923	0.00897	CbGeAlD
Lovastatin—Chills—Azathioprine—Crohn's disease	0.000912	0.00551	CcSEcCtD
Lovastatin—CYP2C9—digestive system—Crohn's disease	0.000909	0.00883	CbGeAlD
Lovastatin—Alopecia—Azathioprine—Crohn's disease	0.000898	0.00543	CcSEcCtD
Lovastatin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000893	0.0054	CcSEcCtD
Lovastatin—Erythema multiforme—Mesalazine—Crohn's disease	0.000876	0.00529	CcSEcCtD
Lovastatin—Chills—Mesalazine—Crohn's disease	0.000831	0.00502	CcSEcCtD
Lovastatin—Diarrhoea—Mercaptopurine—Crohn's disease	0.000829	0.00501	CcSEcCtD
Lovastatin—Ill-defined disorder—Azathioprine—Crohn's disease	0.000821	0.00496	CcSEcCtD
Lovastatin—Alopecia—Mesalazine—Crohn's disease	0.000818	0.00495	CcSEcCtD
Lovastatin—Malaise—Azathioprine—Crohn's disease	0.000798	0.00482	CcSEcCtD
Lovastatin—Flatulence—Mesalazine—Crohn's disease	0.000794	0.0048	CcSEcCtD
Lovastatin—Leukopenia—Azathioprine—Crohn's disease	0.000792	0.00479	CcSEcCtD
Lovastatin—Vascular purpura—Prednisone—Crohn's disease	0.000792	0.00479	CcSEcCtD
Lovastatin—Dysgeusia—Mesalazine—Crohn's disease	0.000789	0.00477	CcSEcCtD
Lovastatin—Back pain—Mesalazine—Crohn's disease	0.00078	0.00471	CcSEcCtD
Lovastatin—ABCC2—lymph node—Crohn's disease	0.000779	0.00757	CbGeAlD
Lovastatin—Muscle spasms—Mesalazine—Crohn's disease	0.000775	0.00468	CcSEcCtD
Lovastatin—Vomiting—Mercaptopurine—Crohn's disease	0.000771	0.00466	CcSEcCtD
Lovastatin—Injury—Prednisone—Crohn's disease	0.00077	0.00466	CcSEcCtD
Lovastatin—Rash—Mercaptopurine—Crohn's disease	0.000764	0.00462	CcSEcCtD
Lovastatin—Dermatitis—Mercaptopurine—Crohn's disease	0.000764	0.00462	CcSEcCtD
Lovastatin—Vision blurred—Mesalazine—Crohn's disease	0.00076	0.00459	CcSEcCtD
Lovastatin—Tremor—Mesalazine—Crohn's disease	0.000755	0.00457	CcSEcCtD
Lovastatin—Amnesia—Prednisone—Crohn's disease	0.000754	0.00456	CcSEcCtD
Lovastatin—Myalgia—Azathioprine—Crohn's disease	0.000753	0.00455	CcSEcCtD
Lovastatin—Arthralgia—Azathioprine—Crohn's disease	0.000753	0.00455	CcSEcCtD
Lovastatin—Ill-defined disorder—Mesalazine—Crohn's disease	0.000748	0.00452	CcSEcCtD
Lovastatin—Discomfort—Azathioprine—Crohn's disease	0.000744	0.0045	CcSEcCtD
Lovastatin—Angioedema—Mesalazine—Crohn's disease	0.000737	0.00445	CcSEcCtD
Lovastatin—Purpura—Prednisone—Crohn's disease	0.000735	0.00444	CcSEcCtD
Lovastatin—Malaise—Mesalazine—Crohn's disease	0.000727	0.00439	CcSEcCtD
Lovastatin—Vertigo—Mesalazine—Crohn's disease	0.000724	0.00438	CcSEcCtD
Lovastatin—Leukopenia—Mesalazine—Crohn's disease	0.000722	0.00436	CcSEcCtD
Lovastatin—Nausea—Mercaptopurine—Crohn's disease	0.00072	0.00435	CcSEcCtD
Lovastatin—Infection—Azathioprine—Crohn's disease	0.000717	0.00434	CcSEcCtD
Lovastatin—Thrombocytopenia—Azathioprine—Crohn's disease	0.000707	0.00427	CcSEcCtD
Lovastatin—CYP3A4—digestive system—Crohn's disease	0.000693	0.00673	CbGeAlD
Lovastatin—Myalgia—Mesalazine—Crohn's disease	0.000686	0.00415	CcSEcCtD
Lovastatin—Chest pain—Mesalazine—Crohn's disease	0.000686	0.00415	CcSEcCtD
Lovastatin—Arthralgia—Mesalazine—Crohn's disease	0.000686	0.00415	CcSEcCtD
Lovastatin—Anxiety—Mesalazine—Crohn's disease	0.000684	0.00413	CcSEcCtD
Lovastatin—CYP2D6—digestive system—Crohn's disease	0.000682	0.00662	CbGeAlD
Lovastatin—Discomfort—Mesalazine—Crohn's disease	0.000678	0.0041	CcSEcCtD
Lovastatin—Dry mouth—Mesalazine—Crohn's disease	0.000671	0.00406	CcSEcCtD
Lovastatin—Confusional state—Mesalazine—Crohn's disease	0.000663	0.00401	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000658	0.00398	CcSEcCtD
Lovastatin—Anaphylactic shock—Mesalazine—Crohn's disease	0.000658	0.00398	CcSEcCtD
Lovastatin—Infection—Mesalazine—Crohn's disease	0.000654	0.00395	CcSEcCtD
Lovastatin—ABCB1—epithelium—Crohn's disease	0.000645	0.00626	CbGeAlD
Lovastatin—Thrombocytopenia—Mesalazine—Crohn's disease	0.000644	0.00389	CcSEcCtD
Lovastatin—Anorexia—Mesalazine—Crohn's disease	0.000627	0.00379	CcSEcCtD
Lovastatin—Pancreatitis—Prednisone—Crohn's disease	0.0006	0.00363	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000599	0.00362	CcSEcCtD
Lovastatin—Feeling abnormal—Azathioprine—Crohn's disease	0.000595	0.0036	CcSEcCtD
Lovastatin—Insomnia—Mesalazine—Crohn's disease	0.000595	0.0036	CcSEcCtD
Lovastatin—Paraesthesia—Mesalazine—Crohn's disease	0.000591	0.00357	CcSEcCtD
Lovastatin—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000591	0.00357	CcSEcCtD
Lovastatin—Dyspnoea—Mesalazine—Crohn's disease	0.000587	0.00355	CcSEcCtD
Lovastatin—Dyspepsia—Mesalazine—Crohn's disease	0.000579	0.0035	CcSEcCtD
Lovastatin—Decreased appetite—Mesalazine—Crohn's disease	0.000572	0.00346	CcSEcCtD
Lovastatin—Abdominal pain—Azathioprine—Crohn's disease	0.000571	0.00345	CcSEcCtD
Lovastatin—Body temperature increased—Azathioprine—Crohn's disease	0.000571	0.00345	CcSEcCtD
Lovastatin—Fatigue—Mesalazine—Crohn's disease	0.000567	0.00343	CcSEcCtD
Lovastatin—Erectile dysfunction—Prednisone—Crohn's disease	0.000564	0.00341	CcSEcCtD
Lovastatin—Constipation—Mesalazine—Crohn's disease	0.000563	0.0034	CcSEcCtD
Lovastatin—Pain—Mesalazine—Crohn's disease	0.000563	0.0034	CcSEcCtD
Lovastatin—ABCB1—mammalian vulva—Crohn's disease	0.000559	0.00543	CbGeAlD
Lovastatin—Feeling abnormal—Mesalazine—Crohn's disease	0.000542	0.00328	CcSEcCtD
Lovastatin—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000538	0.00325	CcSEcCtD
Lovastatin—Neuropathy peripheral—Prednisone—Crohn's disease	0.000535	0.00323	CcSEcCtD
Lovastatin—Hypersensitivity—Azathioprine—Crohn's disease	0.000532	0.00322	CcSEcCtD
Lovastatin—Urticaria—Mesalazine—Crohn's disease	0.000523	0.00316	CcSEcCtD
Lovastatin—Abdominal pain—Mesalazine—Crohn's disease	0.00052	0.00314	CcSEcCtD
Lovastatin—Body temperature increased—Mesalazine—Crohn's disease	0.00052	0.00314	CcSEcCtD
Lovastatin—ABCB1—lymphoid tissue—Crohn's disease	0.000497	0.00482	CbGeAlD
Lovastatin—Diarrhoea—Azathioprine—Crohn's disease	0.000494	0.00299	CcSEcCtD
Lovastatin—ABCB1—digestive system—Crohn's disease	0.000491	0.00476	CbGeAlD
Lovastatin—Hypersensitivity—Mesalazine—Crohn's disease	0.000485	0.00293	CcSEcCtD
Lovastatin—Dizziness—Azathioprine—Crohn's disease	0.000478	0.00289	CcSEcCtD
Lovastatin—Asthenia—Mesalazine—Crohn's disease	0.000472	0.00285	CcSEcCtD
Lovastatin—Pruritus—Mesalazine—Crohn's disease	0.000465	0.00281	CcSEcCtD
Lovastatin—Vomiting—Azathioprine—Crohn's disease	0.000459	0.00278	CcSEcCtD
Lovastatin—Rash—Azathioprine—Crohn's disease	0.000455	0.00275	CcSEcCtD
Lovastatin—Dermatitis—Azathioprine—Crohn's disease	0.000455	0.00275	CcSEcCtD
Lovastatin—Flushing—Prednisone—Crohn's disease	0.000455	0.00275	CcSEcCtD
Lovastatin—Headache—Azathioprine—Crohn's disease	0.000452	0.00274	CcSEcCtD
Lovastatin—Diarrhoea—Mesalazine—Crohn's disease	0.00045	0.00272	CcSEcCtD
Lovastatin—Dizziness—Mesalazine—Crohn's disease	0.000435	0.00263	CcSEcCtD
Lovastatin—Alopecia—Prednisone—Crohn's disease	0.000433	0.00262	CcSEcCtD
Lovastatin—Nausea—Azathioprine—Crohn's disease	0.000429	0.00259	CcSEcCtD
Lovastatin—Vomiting—Mesalazine—Crohn's disease	0.000418	0.00253	CcSEcCtD
Lovastatin—Rash—Mesalazine—Crohn's disease	0.000415	0.00251	CcSEcCtD
Lovastatin—Dermatitis—Mesalazine—Crohn's disease	0.000414	0.00251	CcSEcCtD
Lovastatin—Headache—Mesalazine—Crohn's disease	0.000412	0.00249	CcSEcCtD
Lovastatin—Vision blurred—Prednisone—Crohn's disease	0.000402	0.00243	CcSEcCtD
Lovastatin—Ill-defined disorder—Prednisone—Crohn's disease	0.000396	0.00239	CcSEcCtD
Lovastatin—Nausea—Mesalazine—Crohn's disease	0.000391	0.00236	CcSEcCtD
Lovastatin—Angioedema—Prednisone—Crohn's disease	0.00039	0.00236	CcSEcCtD
Lovastatin—Malaise—Prednisone—Crohn's disease	0.000385	0.00232	CcSEcCtD
Lovastatin—Vertigo—Prednisone—Crohn's disease	0.000383	0.00232	CcSEcCtD
Lovastatin—Arthralgia—Prednisone—Crohn's disease	0.000363	0.00219	CcSEcCtD
Lovastatin—Myalgia—Prednisone—Crohn's disease	0.000363	0.00219	CcSEcCtD
Lovastatin—Anxiety—Prednisone—Crohn's disease	0.000362	0.00219	CcSEcCtD
Lovastatin—Discomfort—Prednisone—Crohn's disease	0.000359	0.00217	CcSEcCtD
Lovastatin—Anaphylactic shock—Prednisone—Crohn's disease	0.000348	0.0021	CcSEcCtD
Lovastatin—Infection—Prednisone—Crohn's disease	0.000346	0.00209	CcSEcCtD
Lovastatin—Anorexia—Prednisone—Crohn's disease	0.000332	0.00201	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000317	0.00192	CcSEcCtD
Lovastatin—Insomnia—Prednisone—Crohn's disease	0.000315	0.0019	CcSEcCtD
Lovastatin—Paraesthesia—Prednisone—Crohn's disease	0.000313	0.00189	CcSEcCtD
Lovastatin—Dyspepsia—Prednisone—Crohn's disease	0.000306	0.00185	CcSEcCtD
Lovastatin—Decreased appetite—Prednisone—Crohn's disease	0.000303	0.00183	CcSEcCtD
Lovastatin—Fatigue—Prednisone—Crohn's disease	0.0003	0.00181	CcSEcCtD
Lovastatin—Constipation—Prednisone—Crohn's disease	0.000298	0.0018	CcSEcCtD
Lovastatin—Feeling abnormal—Prednisone—Crohn's disease	0.000287	0.00173	CcSEcCtD
Lovastatin—Gastrointestinal pain—Prednisone—Crohn's disease	0.000285	0.00172	CcSEcCtD
Lovastatin—ABCB1—lymph node—Crohn's disease	0.00028	0.00272	CbGeAlD
Lovastatin—Urticaria—Prednisone—Crohn's disease	0.000277	0.00167	CcSEcCtD
Lovastatin—Body temperature increased—Prednisone—Crohn's disease	0.000275	0.00166	CcSEcCtD
Lovastatin—Abdominal pain—Prednisone—Crohn's disease	0.000275	0.00166	CcSEcCtD
Lovastatin—Hypersensitivity—Prednisone—Crohn's disease	0.000256	0.00155	CcSEcCtD
Lovastatin—Asthenia—Prednisone—Crohn's disease	0.00025	0.00151	CcSEcCtD
Lovastatin—Pruritus—Prednisone—Crohn's disease	0.000246	0.00149	CcSEcCtD
Lovastatin—Diarrhoea—Prednisone—Crohn's disease	0.000238	0.00144	CcSEcCtD
Lovastatin—Dizziness—Prednisone—Crohn's disease	0.00023	0.00139	CcSEcCtD
Lovastatin—Vomiting—Prednisone—Crohn's disease	0.000221	0.00134	CcSEcCtD
Lovastatin—Rash—Prednisone—Crohn's disease	0.000219	0.00133	CcSEcCtD
Lovastatin—Dermatitis—Prednisone—Crohn's disease	0.000219	0.00133	CcSEcCtD
Lovastatin—Headache—Prednisone—Crohn's disease	0.000218	0.00132	CcSEcCtD
Lovastatin—Nausea—Prednisone—Crohn's disease	0.000207	0.00125	CcSEcCtD
Lovastatin—ITGAL—Immune System—RASGRP1—Crohn's disease	0.000191	0.00199	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—ALB—Crohn's disease	0.000191	0.00199	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CD79A—Crohn's disease	0.00019	0.00198	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—RIPK2—Crohn's disease	0.000187	0.00195	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—TAB1—Crohn's disease	0.000187	0.00195	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—NOD2—Crohn's disease	0.000184	0.00191	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000181	0.00188	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00018	0.00187	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000179	0.00186	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.000178	0.00185	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—JAK2—Crohn's disease	0.000177	0.00185	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—SOCS1—Crohn's disease	0.000173	0.0018	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000171	0.00178	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000171	0.00178	CbGpPWpGaD
Lovastatin—HDAC2—Signaling events mediated by HDAC Class I—TNF—Crohn's disease	0.000168	0.00175	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.000166	0.00173	CbGpPWpGaD
Lovastatin—CYP2C8—Metapathway biotransformation—GPX4—Crohn's disease	0.000165	0.00172	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PLA2G4F—Crohn's disease	0.000156	0.00162	CbGpPWpGaD
Lovastatin—HDAC2—Factors involved in megakaryocyte development and platelet production—JAK2—Crohn's disease	0.000156	0.00162	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL18—Crohn's disease	0.000156	0.00162	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000156	0.00162	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000156	0.00162	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000154	0.0016	CbGpPWpGaD
Lovastatin—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	0.000148	0.00154	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000146	0.00152	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000146	0.00152	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CD4—Crohn's disease	0.000145	0.00151	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000144	0.0015	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00014	0.00146	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL2RA—Crohn's disease	0.000138	0.00144	CbGpPWpGaD
Lovastatin—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.000136	0.00141	CbGpPWpGaD
Lovastatin—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	0.000135	0.0014	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—MTMR3—Crohn's disease	0.000133	0.00138	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000131	0.00136	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CRP—Crohn's disease	0.00013	0.00136	CbGpPWpGaD
Lovastatin—HDAC2—Disease—RSPO3—Crohn's disease	0.00013	0.00135	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.00013	0.00135	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PLA2G4F—Crohn's disease	0.000127	0.00132	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—ZFP36L1—Crohn's disease	0.000127	0.00132	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—TLR4—Crohn's disease	0.000125	0.0013	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SEL1L—Crohn's disease	0.000123	0.00128	CbGpPWpGaD
Lovastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000121	0.00126	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00012	0.00125	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ACKR2—Crohn's disease	0.00012	0.00125	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—ICAM1—Crohn's disease	0.00012	0.00125	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—IL6—Crohn's disease	0.00012	0.00125	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00012	0.00125	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—ITGA4—Crohn's disease	0.000119	0.00124	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.000116	0.00121	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IL3—Crohn's disease	0.000116	0.00121	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MLN—Crohn's disease	0.000114	0.00119	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000112	0.00117	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—RASGRP1—Crohn's disease	0.000112	0.00117	CbGpPWpGaD
Lovastatin—HDAC2—Disease—LTF—Crohn's disease	0.000111	0.00115	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00011	0.00114	CbGpPWpGaD
Lovastatin—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000108	0.00113	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PLA2G4F—Crohn's disease	0.000108	0.00113	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—MTMR3—Crohn's disease	0.000108	0.00113	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—DNMT3A—Crohn's disease	0.000108	0.00112	CbGpPWpGaD
Lovastatin—HDAC2—Chromatin modifying enzymes—JAK2—Crohn's disease	0.000107	0.00112	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000106	0.00111	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TAGAP—Crohn's disease	0.000104	0.00109	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000104	0.00108	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—FADS1—Crohn's disease	0.000103	0.00108	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000103	0.00107	CbGpPWpGaD
Lovastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	9.86e-05	0.00103	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—TYK2—Crohn's disease	9.74e-05	0.00101	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	9.69e-05	0.00101	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GPX4—Crohn's disease	9.67e-05	0.00101	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PLA2G4F—Crohn's disease	9.41e-05	0.00098	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GCKR—Crohn's disease	9.34e-05	0.000973	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—JAK2—Crohn's disease	9.3e-05	0.000968	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	9.27e-05	0.000965	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—MTMR3—Crohn's disease	9.19e-05	0.000957	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IFNG—Crohn's disease	9.12e-05	0.00095	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RSPO3—Crohn's disease	9.11e-05	0.000949	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	9.1e-05	0.000947	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—TYK2—Crohn's disease	9.02e-05	0.000939	CbGpPWpGaD
Lovastatin—HDAC2—Disease—GCKR—Crohn's disease	8.92e-05	0.000928	CbGpPWpGaD
Lovastatin—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	8.88e-05	0.000924	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.83e-05	0.000919	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CD4—Crohn's disease	8.81e-05	0.000918	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PLA2G4F—Crohn's disease	8.78e-05	0.000914	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SEL1L—Crohn's disease	8.64e-05	0.000899	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—JAK2—Crohn's disease	8.6e-05	0.000896	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.45e-05	0.00088	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—FADS1—Crohn's disease	8.42e-05	0.000877	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	8.16e-05	0.000849	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL1B—Crohn's disease	8.14e-05	0.000847	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IL2RA—Crohn's disease	8.11e-05	0.000844	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PLA2G4F—Crohn's disease	8.05e-05	0.000838	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—MTMR3—Crohn's disease	8e-05	0.000833	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCR9—Crohn's disease	7.9e-05	0.000822	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GPX4—Crohn's disease	7.88e-05	0.000821	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SLC11A1—Crohn's disease	7.88e-05	0.000821	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	7.88e-05	0.000821	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IFNG—Crohn's disease	7.64e-05	0.000795	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GCKR—Crohn's disease	7.61e-05	0.000793	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	7.54e-05	0.000785	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—MTMR3—Crohn's disease	7.47e-05	0.000777	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	7.39e-05	0.000769	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GPR65—Crohn's disease	7.34e-05	0.000765	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	7.31e-05	0.000761	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	7.31e-05	0.000761	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—HSPA1B—Crohn's disease	7.28e-05	0.000758	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	7.19e-05	0.000748	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—FADS1—Crohn's disease	7.16e-05	0.000745	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	7.1e-05	0.000739	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.88e-05	0.000716	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—MTMR3—Crohn's disease	6.84e-05	0.000712	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—STAT3—Crohn's disease	6.82e-05	0.00071	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL1B—Crohn's disease	6.81e-05	0.000709	CbGpPWpGaD
Lovastatin—HDAC2—Disease—RBX1—Crohn's disease	6.76e-05	0.000704	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HSPA1B—Crohn's disease	6.76e-05	0.000704	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GPX4—Crohn's disease	6.7e-05	0.000698	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.68e-05	0.000695	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GCKR—Crohn's disease	6.47e-05	0.000674	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	6.45e-05	0.000671	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.44e-05	0.000671	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—UBE2D1—Crohn's disease	6.38e-05	0.000664	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—STAT3—Crohn's disease	6.31e-05	0.000657	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—MTMR3—Crohn's disease	6.28e-05	0.000654	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—FADS1—Crohn's disease	6.23e-05	0.000649	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.14e-05	0.000639	CbGpPWpGaD
Lovastatin—HDAC2—Disease—UBE2D1—Crohn's disease	5.93e-05	0.000617	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—ALB—Crohn's disease	5.86e-05	0.00061	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—IL6—Crohn's disease	5.85e-05	0.000609	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.84e-05	0.000608	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GPX4—Crohn's disease	5.84e-05	0.000608	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—FADS1—Crohn's disease	5.82e-05	0.000606	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.75e-05	0.000599	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GCKR—Crohn's disease	5.64e-05	0.000587	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.6e-05	0.000583	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—JAK2—Crohn's disease	5.45e-05	0.000567	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GPX4—Crohn's disease	5.45e-05	0.000567	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	5.34e-05	0.000556	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—FADS1—Crohn's disease	5.33e-05	0.000555	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GCKR—Crohn's disease	5.26e-05	0.000548	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.24e-05	0.000546	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCR6—Crohn's disease	5.23e-05	0.000545	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.15e-05	0.000537	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GPX4—Crohn's disease	4.99e-05	0.00052	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TNF—Crohn's disease	4.94e-05	0.000515	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—FADS1—Crohn's disease	4.89e-05	0.000509	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GCKR—Crohn's disease	4.82e-05	0.000502	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL6—Crohn's disease	4.77e-05	0.000496	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RBX1—Crohn's disease	4.73e-05	0.000493	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	4.62e-05	0.000481	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTGER4—Crohn's disease	4.61e-05	0.00048	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GPX4—Crohn's disease	4.58e-05	0.000477	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—SMAD3—Crohn's disease	4.57e-05	0.000475	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.56e-05	0.000474	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—MTMR3—Crohn's disease	4.54e-05	0.000473	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GCKR—Crohn's disease	4.42e-05	0.000461	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—IL6—Crohn's disease	4.41e-05	0.000459	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SMAD3—Crohn's disease	4.24e-05	0.000441	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—UBE2D1—Crohn's disease	4.15e-05	0.000432	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	4.13e-05	0.00043	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.03e-05	0.000419	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PLA2G4F—Crohn's disease	4.03e-05	0.000419	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RIPK2—Crohn's disease	4.02e-05	0.000419	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—MTMR3—Crohn's disease	3.93e-05	0.000409	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL3—Crohn's disease	3.92e-05	0.000409	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—ALB—Crohn's disease	3.83e-05	0.000399	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	3.8e-05	0.000395	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RASGRP1—Crohn's disease	3.8e-05	0.000395	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	3.76e-05	0.000392	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	3.61e-05	0.000376	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—FADS1—Crohn's disease	3.54e-05	0.000368	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.52e-05	0.000367	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—MTMR3—Crohn's disease	3.51e-05	0.000365	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	3.49e-05	0.000363	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.45e-05	0.000359	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SOCS1—Crohn's disease	3.44e-05	0.000358	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—MTMR3—Crohn's disease	3.43e-05	0.000357	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GPX4—Crohn's disease	3.31e-05	0.000345	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—ALB—Crohn's disease	3.28e-05	0.000341	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—MTMR3—Crohn's disease	3.23e-05	0.000336	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—MTMR3—Crohn's disease	3.2e-05	0.000333	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GCKR—Crohn's disease	3.2e-05	0.000333	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—FADS1—Crohn's disease	3.06e-05	0.000319	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.01e-05	0.000314	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ALB—Crohn's disease	2.97e-05	0.00031	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SMAD3—Crohn's disease	2.97e-05	0.000309	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GPX4—Crohn's disease	2.87e-05	0.000299	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GCKR—Crohn's disease	2.77e-05	0.000288	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TYK2—Crohn's disease	2.77e-05	0.000288	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL2RA—Crohn's disease	2.75e-05	0.000286	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—FADS1—Crohn's disease	2.73e-05	0.000285	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—FADS1—Crohn's disease	2.67e-05	0.000278	CbGpPWpGaD
Lovastatin—HDAC2—Disease—JAK2—Crohn's disease	2.64e-05	0.000275	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTGS2—Crohn's disease	2.6e-05	0.000271	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GPX4—Crohn's disease	2.56e-05	0.000267	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—FADS1—Crohn's disease	2.51e-05	0.000262	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CD4—Crohn's disease	2.5e-05	0.00026	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GPX4—Crohn's disease	2.5e-05	0.00026	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—FADS1—Crohn's disease	2.49e-05	0.00026	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTGS2—Crohn's disease	2.48e-05	0.000258	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	2.48e-05	0.000258	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GCKR—Crohn's disease	2.47e-05	0.000257	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.44e-05	0.000254	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ALB—Crohn's disease	2.42e-05	0.000252	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GCKR—Crohn's disease	2.41e-05	0.000251	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GPX4—Crohn's disease	2.35e-05	0.000245	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GPX4—Crohn's disease	2.33e-05	0.000243	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GCKR—Crohn's disease	2.27e-05	0.000237	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GCKR—Crohn's disease	2.25e-05	0.000235	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTGS2—Crohn's disease	2.12e-05	0.000221	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MTMR3—Crohn's disease	2.11e-05	0.00022	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ALB—Crohn's disease	2.06e-05	0.000215	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.98e-05	0.000206	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TYK2—Crohn's disease	1.94e-05	0.000202	CbGpPWpGaD
Lovastatin—HDAC2—Disease—STAT3—Crohn's disease	1.94e-05	0.000202	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—JAK2—Crohn's disease	1.85e-05	0.000192	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTGS2—Crohn's disease	1.8e-05	0.000188	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ALB—Crohn's disease	1.79e-05	0.000187	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.77e-05	0.000184	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.73e-05	0.00018	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL8—Crohn's disease	1.69e-05	0.000176	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ALB—Crohn's disease	1.67e-05	0.000174	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—FADS1—Crohn's disease	1.64e-05	0.000171	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.64e-05	0.000171	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.61e-05	0.000168	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGS2—Crohn's disease	1.57e-05	0.000163	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.55e-05	0.000161	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GPX4—Crohn's disease	1.54e-05	0.00016	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ALB—Crohn's disease	1.53e-05	0.00016	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GCKR—Crohn's disease	1.49e-05	0.000155	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—Crohn's disease	1.46e-05	0.000153	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.41e-05	0.000147	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ALB—Crohn's disease	1.41e-05	0.000147	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STAT3—Crohn's disease	1.36e-05	0.000141	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IL6—Crohn's disease	1.35e-05	0.000141	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—Crohn's disease	1.34e-05	0.00014	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—Crohn's disease	1.23e-05	0.000128	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ALB—Crohn's disease	1.02e-05	0.000106	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6—Crohn's disease	9.47e-06	9.86e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—Crohn's disease	8.91e-06	9.27e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ALB—Crohn's disease	8.82e-06	9.18e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ALB—Crohn's disease	7.87e-06	8.19e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—Crohn's disease	7.71e-06	8.03e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ALB—Crohn's disease	7.68e-06	8e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALB—Crohn's disease	7.24e-06	7.54e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALB—Crohn's disease	7.18e-06	7.47e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—Crohn's disease	6.89e-06	7.17e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—Crohn's disease	6.72e-06	7e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—Crohn's disease	6.33e-06	6.59e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—Crohn's disease	6.28e-06	6.54e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALB—Crohn's disease	4.73e-06	4.93e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—Crohn's disease	4.14e-06	4.31e-05	CbGpPWpGaD
